Skip to content

menu

Health Law Pulse logo
HomeAboutContact
Search
Close
RegulatoryEnforcementFDA & Food SafetyTransparencyInternational
View topics Archives
Subscribe

Health Law Pulse

Leading insight on legal developments in the healthcare and life sciences industries.

section 804(j)(2) waivers

Subscribe to section 804(j)(2) waivers via RSS

President Trump unveils executive orders on lowering drug prices

Photo of Mark Faccenda (US)Photo of Jeff Wurzburg (US)Photo of Hayley White (US)
By Mark Faccenda (US), Jeff Wurzburg (US) & Hayley White (US) on July 30, 2020

On Friday, July 24, 2020, President Trump issued three executive orders, and announced a potential fourth executive order, with the stated intention of lowering the cost of prescription drugs in the United States. The general consensus among legal commentators is…

Health Law Pulse

Facebook Twitter RSS LinkedIn YouTube
Published by
Norton Rose Fulbright LLP logo
DisclaimerPrivacy policy

About

Stay up-to-date on healthcare enforcement and regulations with the Health Law Pulse. We give you the news and analysis that matter to your business in a quick, easy-to-read format.

Read more

Topics

Archives

Copyright © 2025, Norton Rose Fulbright LLP. All rights reserved.